{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00088",
      "entity_text" : "ICS",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF12252",
      "entity_text" : "side",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The systemic side effects associated with ICS may cause reluctance among some physicians and patients to use ICS, especially at higher doses and for longer periods that may be required to control more severe and persistent asthma symptoms [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-02T09:06:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T08:57:53Z",
  "trigger" : "cause",
  "evidence" : [ "side effects associated with ICS may cause reluctance among some physicians and patients to use ICS" ],
  "pmc_id" : "4319193",
  "score" : 0
}